Loading...
Avicanna Inc.
AVCN.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.28
CA$0.00(0.00%)
Avicanna Inc. (AVCN.TO) Financial Performance & Income Statement Overview
Review Avicanna Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
51.62%
↑ 51.62%
Operating Income Growth
41.004%
↑ 41.004%
Net Income Growth
58.62%
↑ 58.62%
Operating Cash Flow Growth
-81.39%
↓ 81.39%
Operating Margin
-16.63%
↓ 16.63%
Gross Margin
50.88%
↑ 50.88%
Net Profit Margin
-13.31%
↓ 13.31%
ROE
-381.62%
↓ 381.62%
ROIC
-39.03%
↓ 39.03%
Avicanna Inc. (AVCN.TO) Income Statement & Financial Overview
Review Avicanna Inc.'s (AVCN.TO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.62M | $6.27M | $6.12M | $6.45M |
| Cost of Revenue | $3.17M | $2.70M | $3.24M | $3.39M |
| Gross Profit | $3.45M | $3.57M | $2.88M | $3.05M |
| Gross Profit Ratio | $0.52 | $0.57 | $0.47 | $0.47 |
| R&D Expenses | $5943.00 | $67234.00 | $56260.00 | $48720.00 |
| SG&A Expenses | $4.26M | $3.97M | $4.45M | $3.61M |
| Operating Expenses | $4.67M | $4.35M | $4.51M | $3.66M |
| Total Costs & Expenses | $7.84M | $7.05M | $7.75M | $7.05M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $21986.00 | $54262.00 | $129351.00 | $128048.00 |
| Depreciation & Amortization | $191359.00 | $215871.00 | $222263.00 | $224244.00 |
| EBITDA | $344864.00 | -$516255.00 | -$1.59M | -$665338.00 |
| EBITDA Ratio | $0.05 | -$0.08 | -$0.26 | -$0.10 |
| Operating Income | -$1.22M | -$776000.00 | -$1.63M | -$609170.00 |
| Operating Income Ratio | -$0.18 | -$0.12 | -$0.27 | -$0.09 |
| Other Income/Expenses (Net) | $1.35M | -$10388.00 | -$317739.00 | -$303230.00 |
| Income Before Tax | $131518.00 | -$786388.00 | -$1.95M | -$1.02M |
| Income Before Tax Ratio | $0.02 | -$0.13 | -$0.32 | -$0.16 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$228945.00 |
| Net Income | $131518.00 | -$786388.00 | -$1.95M | -$788687.00 |
| Net Income Ratio | $0.02 | -$0.13 | -$0.32 | -$0.12 |
| EPS | $0.001 | -$0.008 | -$0.02 | -$0.009 |
| Diluted EPS | $0.001 | -$0.008 | -$0.02 | -$0.009 |
| Weighted Avg Shares Outstanding | $100.03M | $100.82M | $93.73M | $90.83M |
| Weighted Avg Shares Outstanding (Diluted) | $100.03M | $100.82M | $93.73M | $90.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan